Olema Pharmaceuticals (OLMA) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

OLMA Olema Pharmaceuticals

Watchlist

10.000
-0.210-2.06%

Close Dec 3 16:00 ET

9.080
-0.920-9.20%

Pre 04:09 ET

572.98MMarket Cap-4385P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire16:30 ET
Express News | Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Reuters16:30 ET
J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating
Moomoo NewsDec 2 19:31 ET · Ratings
Positive Outlook on Olema Pharmaceuticals: Strategic Collaborations and Promising Trial Results Boost Buy Rating
TipRanksDec 2 19:06 ET · Ratings
Olema in Deal With Novartis on Kisqali Breast Cancer Combo Collaboration
Seeking AlphaDec 2 12:07 ET
Sector Update: Health Care Stocks Mixed Pre-Bell Monday
MT NewswiresDec 2 09:14 ET

Comments

Trytosaveabit

Dec 2 06:04

Update

$Olema Pharmaceuticals (OLMA.US)$ Reuters· 3 mins ago
Olema Oncology Announces New Clinical Trial Collaboration and Supply Agreement With Novartis in Frontline Metastatic Breast Cancer as Well as $250 Million Equity Private Placement

Trytosaveabit

Nov 30 10:33

Eyes on! TB on hourly! Plus data release coming could help bring volume to help push this bullish formation!

$Olema Pharmaceuticals (OLMA.US)$ Olema Oncology to Present New Data Combining Palazestrant With Ribociclib at the San Antonio Breast Cancer Symposium
Olema will host an investor conference call at 8:00 a.m. ET on December 10, 2024
Poster Details
Title:A Phase 1b/2 study of palazestrant (OP-1250) in combination with ribociclib, in patients with estrogen receptor-positive, human epidermal gr...

Moomoo AI

Nov 25, 2023 06:49

Although the sale doesn't necessarily signify a negative view on the company's future, absence of insider buying could induce concerns. Other company risks should be considered when investing.

President Sean Bohen Sold A Bunch Of Shares In Olema Pharmaceuticals

Moomoo AI

Oct 17, 2023 06:06

Mr. Garland's expertise in biopharma is predicted to boost late-stage development of Olema's lead product. This could solidify the company's influence in shaping next-gen therapies for women's cancers.

Press Release: Olema Oncology Appoints Oncology Biotech Executive Scott Garland to Board of Directors

Weight-loss drugmakers report strong earnings: Boon or bane?

Trytosaveabit

Oct 12, 2023 06:17

NEWS!

$Olema Pharmaceuticals (OLMA.US)$ Olema Pharmaceuticals Announced New Preclinical Data Regarding The Discovery Of Novel Compounds Targeting KAT6, An Epigenetic Target That Is Dysregulated In Breast And Other Cancers

Heat List

Overall

No Data